CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases

• Yi-Hung Carol Tan,

  Affiliation Department of Life Science, National Taiwan Normal University, Taipei, Taiwan

  ⨯
• Soundararajan Krishnaswamy,

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Suvobroto Nandi,

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Rajani Kanteti,

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Sapana Vora,

  Affiliation Department of Pediatrics, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Kenan Onel,

  Affiliation Department of Pediatrics, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Rifat Hasina,

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Fang-Yi Lo,

  Affiliation Department of Life Science, National Taiwan Normal University, Taipei, Taiwan

  ⨯
• Essam El-Hashani,

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Gustavo Cervantes,

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Matthew Robinson,

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Stephen C. Kales,

  Affiliation Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Stanley Lipkowitz,

  Affiliation Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Theodore Karrison,

  Affiliation Department of Statistics, The University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Martin Sattler,

  Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Everett E. Vokes,

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Yi-Ching Wang,

  Affiliation Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  ⨯
•  [ ... ],
• Ravi Salgia

  * E-mail: rsalgia@medicine.bsd.uchicago.edu

  Affiliation Department of Medicine, The University of Chicago Cancer Research Center, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois, United States of America

  ⨯
• [ view all ]
• [ view less ]